Refining Statin Prescribing in Lower-Risk Individuals: Informing Risk/Benefit Decisions

Ashley Pender, Donald M. Lloyd-Jones, Neil J. Stone, Philip Greenland*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Abstract

Guidelines from the American College of Cardiology/American Heart Association, as well as those from the Veterans Affairs/Department of Defense and the Joint British Societies all recommended treating more people with statins than previous guidelines. In each guideline, the decision-making process began with an assessment of overall cardiovascular risk. Each group proposed updated treatment thresholds, and all of them lowered the threshold compared with earlier guidelines. Since release of these new guidelines in 2013 and 2014, additional evidence has emerged to suggest a rationale for extending statin consideration to an even larger proportion of asymptomatic adults—even those with a 10-year atherosclerotic cardiovascular disease risk below 7.5%. This review discusses new findings since 2013 and proposes strategies emanating from the current guidelines to help clinicians and patients make more informed decisions about long-term statin use, especially pertinent to lower-risk patients.

Original languageEnglish (US)
Pages (from-to)1690-1697
Number of pages8
JournalJournal of the American College of Cardiology
Volume68
Issue number15
DOIs
StatePublished - Oct 11 2016

Keywords

  • atherosclerotic cardiovascular disease
  • coronary artery calcium
  • cost effectiveness
  • primary prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Refining Statin Prescribing in Lower-Risk Individuals: Informing Risk/Benefit Decisions'. Together they form a unique fingerprint.

Cite this